Sherika Hill, PhD MHA

Chief Executive Officer (CEO)
Sherika Hill, PhD MHA

Dr. Sherika Hill has worked at the executive level in industry with over seven years of global pharmaceutical research & development experience as a senior portfolio analyst. During this time she oversaw genetics research strategic initiatives in the US and UK. Dr. Hill spent the past 12 years in academia as a scholar and researcher. She rose to the rank of faculty at Duke in 2019 as a clinical epidemiologist with expertise in child mental health outcomes and policy. Her industry and investigative efforts have focused on measuring and achieving population-level impacts for optimal child development, especially for marginalized communities. Dr. Hill brings a community-focused approach to driving systems change, that is informed by deep experience in maternal-child health, public policy, and healthcare administration.


Skip to content